HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.

Abstract
Listeria monocytogenes is widely used as a model to study immune responses against intracellular bacteria. It has been shown that neutrophils and macrophages play an important role to restrict bacterial replication in the early phase of primary infection in mice, and that the cytokines interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) are essential for protection. However, the involved signaling pathways and effector mechanisms are still poorly understood. This study investigated mouse strains deficient for the IFN-dependent transcription factors interferon consensus sequence binding protein (ICSBP), interferon regulatory factor (IRF) 1 or 2 for their capacity to eliminate Listeria in vivo and in vitro and for production of inducible reactive nitrogen intermediates (RNI) or reactive oxygen intermediates (ROI) in macrophages. ICSBP-/- and to a lesser degree also IRF2-/- mice were highly susceptible to Listeria infection. This correlated with impaired elimination of Listeria from infected peritoneal macrophage (PEM) cultures stimulated with IFN-gamma in vitro; in addition these cultures showed reduced and delayed oxidative burst upon IFN-gamma stimulation, whereas nitric oxide production was normal. In contrast, mice deficient for IRF1 were not able to produce nitric oxide, but they efficiently controlled Listeria in vivo and in vitro. These results indicate that (a) the ICSBP/IRF2 complex is essential for IFN-gamma-mediated protection against Listeria and that (b) ROI together with additional still unknown effector mechanisms may be responsible for the anti-Listeria activity of macrophages, whereas IRF1-induced RNI are not limiting.
AuthorsT Fehr, G Schoedon, B Odermatt, T Holtschke, M Schneemann, M F Bachmann, T W Mak, I Horak, R M Zinkernagel
JournalThe Journal of experimental medicine (J Exp Med) Vol. 185 Issue 5 Pg. 921-31 (Mar 03 1997) ISSN: 0022-1007 [Print] United States
PMID9120398 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • DNA-Binding Proteins
  • Interferon Regulatory Factor-1
  • Interferon Regulatory Factor-2
  • Interferon Regulatory Factors
  • Irf1 protein, mouse
  • Irf2 protein, mouse
  • Phosphoproteins
  • Reactive Oxygen Species
  • Repressor Proteins
  • Transcription Factors
  • interferon regulatory factor-8
  • Nitric Oxide
  • Interferon-gamma
Topics
  • Adoptive Transfer
  • Animals
  • Carrier Proteins (genetics, metabolism)
  • Cell Transplantation
  • Cells, Cultured
  • DNA-Binding Proteins (genetics, metabolism)
  • Disease Susceptibility
  • Immunity, Innate
  • Interferon Regulatory Factor-1
  • Interferon Regulatory Factor-2
  • Interferon Regulatory Factors
  • Interferon-gamma
  • Listeriosis (immunology)
  • Liver (microbiology)
  • Macrophages, Peritoneal (cytology, drug effects, immunology, microbiology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Models, Biological
  • Nitric Oxide (metabolism)
  • Phosphoproteins (genetics, metabolism)
  • Reactive Oxygen Species
  • Repressor Proteins
  • Respiratory Burst
  • Signal Transduction
  • Species Specificity
  • Spleen (cytology, microbiology, transplantation)
  • Transcription Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: